The novel and selective insulin-like growth factor-1 receptor kinase inhibitor pqip suppresses bone cell function and osteoclast-breast cancer cell cross-talk

J. G. Logan, A. Sophocleous, E. Landao-Bassonga, V. G. Brunton, A. I. Idris

Research output: Contribution to journalBook/Film/Article reviewpeer-review

Fingerprint

Dive into the research topics of 'The novel and selective insulin-like growth factor-1 receptor kinase inhibitor pqip suppresses bone cell function and osteoclast-breast cancer cell cross-talk'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science